UniProt ID | EIF3I_HUMAN | |
---|---|---|
UniProt AC | Q13347 | |
Protein Name | Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008} | |
Gene Name | EIF3I {ECO:0000255|HAMAP-Rule:MF_03008} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 325 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. [PubMed: 17581632] | |
Protein Sequence | MKPILLQGHERSITQIKYNREGDLLFTVAKDPIVNVWYSVNGERLGTYMGHTGAVWCVDADWDTKHVLTGSADNSCRLWDCETGKQLALLKTNSAVRTCGFDFGGNIIMFSTDKQMGYQCFVSFFDLRDPSQIDNNEPYMKIPCNDSKITSAVWGPLGECIIAGHESGELNQYSAKSGEVLVNVKEHSRQINDIQLSRDMTMFVTASKDNTAKLFDSTTLEHQKTFRTERPVNSAALSPNYDHVVLGGGQEAMDVTTTSTRIGKFEARFFHLAFEEEFGRVKGHFGPINSVAFHPDGKSYSSGGEDGYVRIHYFDPQYFEFEFEA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Sumoylation | ------MKPILLQGH ------CCCEEECCC | 40.54 | - | |
2 | Sumoylation | ------MKPILLQGH ------CCCEEECCC | 40.54 | - | |
2 | Ubiquitination | ------MKPILLQGH ------CCCEEECCC | 40.54 | 21906983 | |
14 | Phosphorylation | QGHERSITQIKYNRE CCCCCEEEEEEECCC | 26.03 | - | |
17 | Ubiquitination | ERSITQIKYNREGDL CCEEEEEEECCCCCE | 27.01 | 21906983 | |
17 | Acetylation | ERSITQIKYNREGDL CCEEEEEEECCCCCE | 27.01 | 26051181 | |
30 | Ubiquitination | DLLFTVAKDPIVNVW CEEEEEECCCEEEEE | 60.75 | 21906983 | |
30 | Acetylation | DLLFTVAKDPIVNVW CEEEEEECCCEEEEE | 60.75 | 7666227 | |
65 | Ubiquitination | VDADWDTKHVLTGSA EECCCCCCEEEECCC | 29.28 | - | |
69 | Phosphorylation | WDTKHVLTGSADNSC CCCCEEEECCCCCCC | 28.18 | 30108239 | |
71 | Phosphorylation | TKHVLTGSADNSCRL CCEEEECCCCCCCEE | 27.49 | 30108239 | |
75 | Phosphorylation | LTGSADNSCRLWDCE EECCCCCCCEEEECC | 10.93 | 30108239 | |
77 | Methylation | GSADNSCRLWDCETG CCCCCCCEEEECCCC | 38.34 | - | |
85 | Acetylation | LWDCETGKQLALLKT EEECCCCCEEEEEEC | 49.94 | 26051181 | |
85 | Ubiquitination | LWDCETGKQLALLKT EEECCCCCEEEEEEC | 49.94 | 21906983 | |
91 | Acetylation | GKQLALLKTNSAVRT CCEEEEEECCCCCHH | 46.65 | 25953088 | |
91 | Ubiquitination | GKQLALLKTNSAVRT CCEEEEEECCCCCHH | 46.65 | 21890473 | |
139 | Phosphorylation | QIDNNEPYMKIPCND HCCCCCCCEECCCCC | 12.59 | - | |
140 | Sulfoxidation | IDNNEPYMKIPCNDS CCCCCCCEECCCCCH | 4.67 | 21406390 | |
141 | Acetylation | DNNEPYMKIPCNDSK CCCCCCEECCCCCHH | 37.34 | 26051181 | |
141 | Ubiquitination | DNNEPYMKIPCNDSK CCCCCCEECCCCCHH | 37.34 | - | |
144 | S-nitrosylation | EPYMKIPCNDSKITS CCCEECCCCCHHHEE | 11.42 | 19483679 | |
144 | S-nitrosocysteine | EPYMKIPCNDSKITS CCCEECCCCCHHHEE | 11.42 | - | |
148 | Ubiquitination | KIPCNDSKITSAVWG ECCCCCHHHEEEEEC | 53.52 | - | |
148 | Acetylation | KIPCNDSKITSAVWG ECCCCCHHHEEEEEC | 53.52 | 26051181 | |
176 | Ubiquitination | ELNQYSAKSGEVLVN CCCCCCCCCCCEEEE | 53.72 | - | |
185 | Sumoylation | GEVLVNVKEHSRQIN CCEEEEHHHHHHHCC | 44.50 | - | |
185 | Acetylation | GEVLVNVKEHSRQIN CCEEEEHHHHHHHCC | 44.50 | 27452117 | |
185 | Sumoylation | GEVLVNVKEHSRQIN CCEEEEHHHHHHHCC | 44.50 | - | |
185 | 2-Hydroxyisobutyrylation | GEVLVNVKEHSRQIN CCEEEEHHHHHHHCC | 44.50 | - | |
185 | Ubiquitination | GEVLVNVKEHSRQIN CCEEEEHHHHHHHCC | 44.50 | 21906983 | |
200 | Sulfoxidation | DIQLSRDMTMFVTAS EEECCCCCEEEEEEC | 2.58 | 21406390 | |
201 | Phosphorylation | IQLSRDMTMFVTASK EECCCCCEEEEEECC | 16.25 | 20068231 | |
202 | Sulfoxidation | QLSRDMTMFVTASKD ECCCCCEEEEEECCC | 1.72 | 30846556 | |
205 | Phosphorylation | RDMTMFVTASKDNTA CCCEEEEEECCCCCC | 17.59 | 20068231 | |
207 | Phosphorylation | MTMFVTASKDNTAKL CEEEEEECCCCCCCC | 31.04 | 20068231 | |
208 | Ubiquitination | TMFVTASKDNTAKLF EEEEEECCCCCCCCC | 53.16 | 21906983 | |
213 | Ubiquitination | ASKDNTAKLFDSTTL ECCCCCCCCCCCCCC | 47.88 | 21906983 | |
213 | 2-Hydroxyisobutyrylation | ASKDNTAKLFDSTTL ECCCCCCCCCCCCCC | 47.88 | - | |
213 | Sumoylation | ASKDNTAKLFDSTTL ECCCCCCCCCCCCCC | 47.88 | - | |
213 | Sumoylation | ASKDNTAKLFDSTTL ECCCCCCCCCCCCCC | 47.88 | - | |
213 | Acetylation | ASKDNTAKLFDSTTL ECCCCCCCCCCCCCC | 47.88 | 25953088 | |
217 | Phosphorylation | NTAKLFDSTTLEHQK CCCCCCCCCCCEEEC | 18.89 | 26434776 | |
218 | Phosphorylation | TAKLFDSTTLEHQKT CCCCCCCCCCEEECE | 36.93 | 26434776 | |
219 | Phosphorylation | AKLFDSTTLEHQKTF CCCCCCCCCEEECEE | 33.82 | 26434776 | |
224 | Ubiquitination | STTLEHQKTFRTERP CCCCEEECEECCCCC | 52.09 | 21906983 | |
224 | Acetylation | STTLEHQKTFRTERP CCCCEEECEECCCCC | 52.09 | 26051181 | |
234 | Phosphorylation | RTERPVNSAALSPNY CCCCCCCCCCCCCCC | 18.36 | - | |
238 | Phosphorylation | PVNSAALSPNYDHVV CCCCCCCCCCCCEEE | 13.33 | 25159151 | |
241 | Phosphorylation | SAALSPNYDHVVLGG CCCCCCCCCEEEECC | 15.71 | 22817900 | |
256 | Phosphorylation | GQEAMDVTTTSTRIG CCEEEECEECCCCEE | 21.79 | 26434776 | |
257 | Phosphorylation | QEAMDVTTTSTRIGK CEEEECEECCCCEEE | 20.71 | 26434776 | |
258 | Phosphorylation | EAMDVTTTSTRIGKF EEEECEECCCCEEEE | 20.80 | 26434776 | |
259 | Phosphorylation | AMDVTTTSTRIGKFE EEECEECCCCEEEEE | 17.37 | 28857561 | |
260 | Phosphorylation | MDVTTTSTRIGKFEA EECEECCCCEEEEEE | 24.98 | 28857561 | |
264 | Ubiquitination | TTSTRIGKFEARFFH ECCCCEEEEEEEHHH | 37.35 | 21890473 | |
264 | Malonylation | TTSTRIGKFEARFFH ECCCCEEEEEEEHHH | 37.35 | 26320211 | |
264 | Acetylation | TTSTRIGKFEARFFH ECCCCEEEEEEEHHH | 37.35 | 19608861 | |
282 | Sumoylation | EEEFGRVKGHFGPIN HHHHCCCCCCCCCCC | 45.36 | - | |
282 | Sumoylation | EEEFGRVKGHFGPIN HHHHCCCCCCCCCCC | 45.36 | - | |
282 | Acetylation | EEEFGRVKGHFGPIN HHHHCCCCCCCCCCC | 45.36 | 26051181 | |
282 | Ubiquitination | EEEFGRVKGHFGPIN HHHHCCCCCCCCCCC | 45.36 | 21890473 | |
298 | Acetylation | VAFHPDGKSYSSGGE EEECCCCCCCCCCCC | 54.31 | 26051181 | |
298 | 2-Hydroxyisobutyrylation | VAFHPDGKSYSSGGE EEECCCCCCCCCCCC | 54.31 | - | |
298 | Ubiquitination | VAFHPDGKSYSSGGE EEECCCCCCCCCCCC | 54.31 | 21890473 | |
299 | Phosphorylation | AFHPDGKSYSSGGED EECCCCCCCCCCCCC | 35.46 | 28152594 | |
300 | Phosphorylation | FHPDGKSYSSGGEDG ECCCCCCCCCCCCCC | 15.44 | 28152594 | |
301 | Phosphorylation | HPDGKSYSSGGEDGY CCCCCCCCCCCCCCE | 29.60 | 28152594 | |
302 | Phosphorylation | PDGKSYSSGGEDGYV CCCCCCCCCCCCCEE | 42.45 | 28152594 | |
308 | Nitration | SSGGEDGYVRIHYFD CCCCCCCEEEEEEEC | 10.01 | - | |
308 | Phosphorylation | SSGGEDGYVRIHYFD CCCCCCCEEEEEEEC | 10.01 | 20090780 | |
318 | Phosphorylation | IHYFDPQYFEFEFEA EEEECCCEEEEEEEC | 15.51 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EIF3I_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EIF3I_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EIF3I_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-264, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-308, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-308, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-282, AND MASSSPECTROMETRY. |